Position in JNJ
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$2,307,317
+$401,663 QoQ
Shares Held
9,085
+16.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.84%
of 13F equity value
Holder Rank
#2,230
of 4,676 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Integris Wealth Management, LLC holds $4,132,813 across 3 Drug Manufacturers - General names. JNJ ranks #1 (55.8% of the industry book) .
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,307,317 | 9,085 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,905,654 | 7,796 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,623,108 | 7,843 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,510,245 | 8,145 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,244,148 | 8,145 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,299,356 | 7,835 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,130,928 | 7,820 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,424,669 | 8,791 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,270,276 | 8,691 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,182,470 | 7,475 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,171,631 | 7,475 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,164,231 | 7,475 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,240,572 | 7,495 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,177,225 | 7,595 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,323,991 | 7,495 | Shares | Sole | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||